CD134/OX40 Polyclonal antibody
CD134/OX40 Polyclonal Antibody for WB, FC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
WB, FC, ELISA
Conjugate
Unconjugated
验证数据展示
经过测试的应用
Positive WB detected in | MJ cells |
Positive FC detected in | PHA treated human PBMCs |
推荐稀释比
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 2 publications below |
产品信息
20006-1-AP targets CD134/OX40 in WB, FC, ELISA applications and shows reactivity with human samples.
Tested Applications | WB, FC, ELISA Application Description |
Cited Applications | WB |
Tested Reactivity | human |
Cited Reactivity | human |
Immunogen | Peptide 种属同源性预测 |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Full Name | tumor necrosis factor receptor superfamily, member 4 |
Synonyms | TNFRSF4, TXGP1L, ACT35, ACT35 antigen, CD134, OX40, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor |
Calculated Molecular Weight | 29 kDa |
Observed Molecular Weight | 50-55 kDa, 40 kDa |
GenBank Accession Number | NM_003327 |
Gene Symbol | CD134 |
Gene ID (NCBI) | 7293 |
RRID | AB_10733472 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | P43489 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
WB protocol for CD134/OX40 antibody 20006-1-AP | Download protocol |
FC protocol for CD134/OX40 antibody 20006-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Front Immunol A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study | ||
Dis Markers Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma |